NCT03475979View on ClinicalTrials.gov

Abbreviated Breast MRI for Second Breast Cancer Detection in Women With BRCA Mutation Testing

UnknownOBSERVATIONAL
Enrollment

1,564

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Breast CancerBRCA1 MutationBRCA2 MutationRecurrent Breast CancerMetachronous Neoplasm
Trial Locations (1)

Unknown

RECRUITING

Seoul National University Hospital, Seoul

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Korean Society of Breast Imaging & Korean Society For Breast Screening

UNKNOWN

collaborator

Bayer

INDUSTRY

lead

Seoul National University Hospital

OTHER